Richmond, VA 的 喉癌 臨床試驗
6 項針對 喉癌 的研究正在 Richmond（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
招募中3 期
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
招募中2 期
- VCU Massey Comprehensive Cancer Center, Richmond
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
招募中2 期
- Virginia Cancer Institute, Richmond
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
招募中1 期
- VCU Massey Comprehensive Cancer Center, Richmond
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
招募中2 期
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
招募中2 期
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
其他城市的 喉癌 試驗
- Atlanta, GA8 項研究
- Chicago, IL8 項研究
- Milwaukee, WI8 項研究
- Kansas City, MO7 項研究
- Portland, OR7 項研究
- St. Louis, MO7 項研究
- Baltimore, MD6 項研究
- Edison, NJ6 項研究
- Cincinnati, OH6 項研究
- Durham, NC6 項研究
- Pittsburgh, PA6 項研究
- Kansas City, KS5 項研究
Richmond 的其他研究
- 乳癌26 項研究
- 非小細胞肺癌25 項研究
- 前列腺癌19 項研究
- 心臟衰竭16 項研究
- 肺癌14 項研究
- 心血管疾病13 項研究
- 大腸直腸癌13 項研究
- 脂肪性肝病12 項研究
- 急性髓系白血病12 項研究
- 轉移性癌症12 項研究
- 頭頸部鱗狀細胞癌12 項研究
- 黑色素瘤11 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。